| Journal Profile | |||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Journal Title | Advanced Therapeutics | ||||||||||||||||||||||||||||||||||||
| Journal Title Abbreviations | |||||||||||||||||||||||||||||||||||||
| ISSN | 2366-3987 | ||||||||||||||||||||||||||||||||||||
| h-index | N.A. | ||||||||||||||||||||||||||||||||||||
| CiteScore |
| ||||||||||||||||||||||||||||||||||||
| Self-Citation Ratio (2020-2021) | N/A | ||||||||||||||||||||||||||||||||||||
| 期刊简介 | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. | ||||||||||||||||||||||||||||||||||||
| Official Website | |||||||||||||||||||||||||||||||||||||
| Online Manuscript Submission | |||||||||||||||||||||||||||||||||||||
| Open Access | No | ||||||||||||||||||||||||||||||||||||
| Publisher | |||||||||||||||||||||||||||||||||||||
| Subject Area | Pharmacology, Toxicology and Pharmaceutics | ||||||||||||||||||||||||||||||||||||
| Country/Area of Publication | |||||||||||||||||||||||||||||||||||||
| Publication Frequency | |||||||||||||||||||||||||||||||||||||
| Year Publication Started | 0 | ||||||||||||||||||||||||||||||||||||
| Annual Article Volume | 162 | ||||||||||||||||||||||||||||||||||||
| Gold OA文章占比 | |||||||||||||||||||||||||||||||||||||
| OA期刊相关信息 | |||||||||||||||||||||||||||||||||||||
| WOS期刊SCI分区 | |||||||||||||||||||||||||||||||||||||
| Indexing (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||||||||||||||
| Link to PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2366-3987%5BISSN%5D | ||||||||||||||||||||||||||||||||||||
| Average Duration of Peer Review * | Authorized Data from Publisher: Data from Authors: | ||||||||||||||||||||||||||||||||||||
| Competitiveness * | Data from Authors: | ||||||||||||||||||||||||||||||||||||
| Useful Links |
| ||||||||||||||||||||||||||||||||||||
| *All review process metrics, such as acceptance rate and review speed, are limited to our user-submitted manuscripts. As such they may not reflect the journals' exact competitiveness or speed. | |||||||||||||||||||||||||||||||||||||
|
|
| |
| First Previous 1 Next Last (To Page | |
| Reviews on Advanced Therapeutics: | Write a review |
| Author: Jamie0703 Subject Area: Engineering Duration of Peer Review: 0.0 month(s) Result: Pending & Unknown Write a review |
Reviewed 2024-01-23 00:00:31 2023-12-15 Major revision 2024-01-09 Revision  (0) Thank | Jamie0703  |
| Author: Jamie0703 Subject Area: Engineering Duration of Peer Review: 0.0 month(s) Result: Pending & Unknown Write a review |
Reviewed 2023-12-05 15:20:38 Submitted on 2023-11-08 Under review on 2023-11-17 Up to now (0) Thank | Jamie0703 |
| Author: little Subject Area: Life Science学 Duration of Peer Review: 0.0 month(s) Result: Pending & Unknown Write a review |
Reviewed 2022-11-12 22:40:26 Posted on September 15th, received the review information on November 28th. One minor revision and one rejection (no specific feedback was given, only mentioned the lack of innovation). The rejection was given by the editor. The process took a long time, so be cautious about submitting if time is tight. (1) Thank | little |
| Author: qiyedl Subject Area: Engineering Duration of Peer Review: 1.0 month(s) Result: Accepted after revision Write a review |
Reviewed 2022-04-21 12:18:14 2.13 Under Consideration 2.25 Revision - Super fast review speed There are many experts publishing reviews and research papers. Now the Advanced series has updated the review status, including Manuscript Submitted, With Editor, Under Review, and other statuses. (16) Thank | qiyedl |
| First Previous 1 Next Last (To Page | |